Common use of NON-ANTIBODY PRODUCTS Clause in Contracts

NON-ANTIBODY PRODUCTS. Notwithstanding anything in this Agreement to the contrary, each Party does hereby retain the right to (i) enter into collaborations with, and to grant licenses and other rights under its respective Technology (other than Collaboration Technology, which shall be governed by Section 7.1.5) to, Third Parties to Exploit products other than antibody-based products with respect to Collaboration Targets without use or reference to the other Party's technology, and/or (ii) independently Exploit products other than antibody-based products with respect to Collaboration Targets.

NON-ANTIBODY PRODUCTS. Notwithstanding anything in this Agreement to the contrary, each Party does hereby retain the right to (i) enter into collaborations with, and to grant licenses and other rights under its respective Technology (other than Collaboration Joint Technology, which shall be governed by Section 7.1.5) to, Third Parties to Exploit products other than antibody-based products [*] with respect to Collaboration Targets without use or reference to the other Party's technologyTargets, and/or (ii) independently Exploit products other than antibody-based products [*] with respect to Collaboration TargetsTargets (without the use of or reference to the other Party's Technology).

NON-ANTIBODY PRODUCTS. Notwithstanding anything in this Agreement to the contrary, each Party does hereby shall have and retain the right to (i) enter into collaborations with, and to grant licenses and other rights under its respective Technology (other than Joint Technology and Collaboration Technology, which shall be governed by Section 7.1.55.1.3 and the Collaboration Agreement, respectively) to, Third Parties to Exploit products other than antibody-based products with respect to Collaboration Targets without use or reference to the other Party's technologyUnilateral Targets, and/or (ii) independently Exploit products other than antibody-based products with respect to Collaboration Unilateral Targets.